Laila Impex
Records under this name other than the patents Laila Impex holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,524,769 | Process for producing a fraction enriched up to 100% of 3-O-acetyl-11-keto-beta-boswellic acid from an extract containing a mixture of boswellic acids Lapsed on the fee record Ended Sep 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2025 | From the USPTO record |
| US 8,420,132 | Synergistic anti-inflammatory and antioxidant dietary supplement compositions Lapsed on the fee record Ended Apr 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2025 | From the USPTO record |
| US 7,208,615 | Triple mineral salts of (-)-hydroxycitric acid and processes for preparing the same Term ended Term ended Nov 1, 2024 · From the USPTO record | Term ended | Term ended Nov 1, 2024 | From the USPTO record |
| US 8,192,768 | Synergistic anti-inflammatory and antioxidant dietary supplement compositions Lapsed on the fee record Ended Jun 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2024 | From the USPTO record |
| US 6,875,891 | Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts Term ended Term ended Mar 19, 2024 · From the USPTO record | Term ended | Term ended Mar 19, 2024 | From the USPTO record |
| US 7,741,370 | Double salts of (−)-hydroxycitric acid and a process for preparing the same Lapsed on the fee record Ended Jun 22, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2022 | From the USPTO record |
| US 8,541,381 | Process for producing enriched fractions containing up to 100% of bacopasaponins from the plant materials of bacopa species Lapsed on the fee record Ended Sep 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2021 | From the USPTO record |
| US 7,780,997 | Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith Lapsed on the fee record Ended Aug 24, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2018 | From the USPTO record |
| US 7,026,518 | Resveratrol analogs Lapsed on the fee record Ended Apr 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 11, 2018 | From the USPTO record |
| US 8,568,802 | Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahydroxy-curcumin from the extracts of Curcuma longa Lapsed on the fee record Ended Oct 29, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2017 | From the USPTO record |